Tyrosinemia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2023-06-05
EMA Authorised: Nityr (nitisinone) — Cycle Pharmaceuticals (Europe) Ltd
Nityr (nitisinone) has been authorised in Europe for treatment of tyrosinemias.